Ipca Laboratories has acquired further 13.09% of the paid-up equity share capital of Trophic Wellness (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals underthe brand name ‘Nutricharge’.
With this acquisition of these 13.09% of the equity share capital, the said Trophic Wellness has become a subsidiary of the Company. The Company now holds 52.35% of the paid-up equity share capital of TWPL.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
